Navigating rare disease drug development requires coordinated, adaptive strategies as science and regulation evolve in parallel. Small, geographically dispersed patient populations, limited natural history data, and heterogeneous disease progression make trial design and execution unusually complex. At the same time,...
Expertise: Rare Disease 83 results
Since PDUFA VII was signed into law in September 2022, the U.S. Food and Drug Administration (FDA) has introduced a series of initiatives aimed at addressing the persistent challenges of rare disease development. Collectively, these efforts form a more complete...
In rare disease research, every patient counts. Recruitment is challenging, retention even harder, and each data point is invaluable. Yet rigid trial protocols often create unnecessary barriers for patients, families, and sites alike. For rare conditions where participants are geographically...
Each year on September 17th, the World Health Organization recognizes World Patient Safety Day to raise awareness and promote action to reduce patient harm. This year’s theme, “Ensuring safe care for every newborn and child,” highlights the importance of protecting...
Rare disease trials face some of the most complex challenges in drug development. Patient populations are small and geographically dispersed. Protocols are often demanding, with intensive procedures and long travel requirements. Families are already carrying the burden of managing a...
Rare Disease
Rare Trials Summit
Rare Disease
World Orphan Drug Congress EU
Rare Disease
OCT Southern California
Rare Disease